The role of smart devices and mobile application on the change in peak VO2 in patients with high cardiovascular risk: a sub-study of the LIGHT randomised clinical trial


HAYIROĞLU M. İ., Çınar T., Cilli Hayıroğlu S., ŞAYLIK F., Uzun M., Tekkeşin A. İ.

Acta Cardiologica, cilt.78, sa.9, ss.1000-1005, 2023 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 78 Sayı: 9
  • Basım Tarihi: 2023
  • Doi Numarası: 10.1080/00015385.2023.2223005
  • Dergi Adı: Acta Cardiologica
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE
  • Sayfa Sayıları: ss.1000-1005
  • Anahtar Kelimeler: Mobile application, cardiopulmonary exercise test, digital health intervention
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Background: This investigation aims to assess the influence of a mobile application and smart devices on cardiopulmonary exercise testing (CPET) over a one-year period in individuals who have high risk for cardiovascular disease. Methods: This is a post-hoc subgroup analysis of Lifestyle Intervention Using Mobile Technology in Patients with High Cardiovascular Risk: A Pragmatic Randomised Clinical Trial (LIGHT). In the intervention plus standard care standard standard care arms, 138 and 103 patients were recruited, respectively. The 1-year VO2 measurements were adjusted to the baseline VO2 measurements as the study’s endpoint. VO2 measurements were taken for each subject during the randomisation and final CPET examinations. Results: The intervention plus standard care improved VO2 measurements by 1.1 (adjusted treatment effect 1.1, 95% confidence interval (CI): 0.8, 1.4, p < 0.001) compared to standard care following 1-year follow-up. Conclusion: At a 1-year follow-up, the smart device and mobile application technologies increased VO2 measurements in individuals with high cardiovascular risk compared to conventional treatment alone.